BIO vs TFSL · rev $651.0M vs P/E 49, rev $595.4M
BIO (BIO) versus TFS Financial Corporation (TFSL) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
TFS Financial Corporation (TFSL) is a banks - regional company listed on NASDAQ.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported TFSL revenue for 2026-06-30 was $595.4M. Net income was $76.1M. Revenue was up 51.4% from 2026-03-31 to 2026-06-30. TFSL currently screens at market cap $4.56B and trailing P/E 49.3.
BIO currently screens at market cap $0. TFSL currently screens at market cap $4.56B and trailing P/E 49.3.
Not investment advice. Open the BIO and TFSL stock pages for the full models.
Not investment advice.